How Does Nevanac Work? Mechanism of Action Explained in Plain English

Nevanac (nepafenac) is described as a prodrug — a term that sometimes leaves patients puzzled. What does it actually mean, and why does it matter for how well the drug works after cataract surgery? Here's a clear, plain-English explanation of Nevanac's mechanism of action.

What Problem Does Nevanac Solve?

Cataract surgery involves making a small incision in the eye, removing the cloudy natural lens, and replacing it with an artificial intraocular lens (IOL). Even in skilled hands, this process triggers an inflammatory response — the eye's natural reaction to any trauma.

This inflammation is driven largely by prostaglandins — chemical messengers your body produces in response to tissue injury. Prostaglandins cause pain, redness, and swelling. They can also increase the risk of cystoid macular edema (CME), a condition where fluid builds up in the central part of the retina and can seriously impair your vision. Nevanac's job is to block prostaglandin production.

What Does 'Prodrug' Mean?

A prodrug is a medication that is not active on its own. Instead, it must first be converted by the body into its active form to produce its therapeutic effect. Think of it like a locked door: the prodrug is the key, but it needs to be "cut" into the right shape before it can open anything.

Nepafenac — the active ingredient in Nevanac — is a prodrug of amfenac. When you place Nevanac drops in your eye, the nepafenac molecule is inactive. To do its work, it must first be converted into amfenac.

Step by Step: How Nevanac Works in the Eye

You apply the drop to your eye. Nepafenac lands on the surface of the eye in its prodrug (inactive) form.

It rapidly penetrates the cornea. Nepafenac is formulated to penetrate the cornea quickly. Research has shown that it crosses the cornea approximately 6 times faster than diclofenac (another ophthalmic NSAID). This speed is one of nepafenac's key advantages.

It's converted to amfenac inside the eye. Once inside the eye, special enzymes called hydrolases (produced by ocular tissues) convert nepafenac into amfenac — its active form. This conversion happens relatively quickly; onset of activity is approximately 15 minutes after application.

Amfenac blocks COX enzymes. Amfenac inhibits cyclooxygenase (COX-1 and COX-2) — enzymes required for the production of prostaglandins. By blocking COX enzymes, amfenac prevents prostaglandin synthesis in the eye.

Inflammation and pain decrease. With fewer prostaglandins, the inflammatory cascade is disrupted — reducing pain, swelling, redness, and the risk of macular edema after surgery.

Why Is the Prodrug Design an Advantage?

The prodrug design of nepafenac offers several theoretical advantages over conventional NSAID eye drops:

Better corneal penetration: The inactive nepafenac molecule is more lipophilic (fat-soluble) than amfenac, allowing it to pass through the lipid-rich corneal epithelium more easily

Targeted activation: The drug becomes active where it's needed — inside the eye — rather than at the eye's surface

Minimal corneal surface activity: Because the NSAID isn't active until inside the eye, there is less direct NSAID exposure to the vulnerable corneal epithelium — potentially reducing stinging and corneal toxicity compared to active-form NSAIDs like ketorolac

Long duration of action: Nevanac provides more than 8 hours of anti-inflammatory activity after a single dose, enabling effective coverage with three-times-daily dosing

How Does Nevanac Compare to Other Ophthalmic NSAIDs?

All ophthalmic NSAIDs used for cataract surgery work by the same basic mechanism — blocking COX enzymes and reducing prostaglandin production. The differences are in how well they penetrate the cornea, how long they last, and how much they affect the corneal surface.

Ketorolac: Active form applied directly; good efficacy; more stinging; shorter duration; less corneal penetration than nepafenac

Bromfenac: Active form; highly lipophilic for good corneal penetration; long duration (once daily); very potent COX-2 inhibitor

Diclofenac: Active form; needs four-times-daily dosing; good for anterior segment; less corneal penetration than nepafenac

Nepafenac (Nevanac): Prodrug; fastest corneal penetration of all ophthalmic NSAIDs; activated inside the eye; three-times-daily dosing; targets both anterior and posterior segments

The Bottom Line

Nevanac works by entering the eye in an inactive prodrug form, being converted to amfenac by ocular enzymes, and then blocking COX enzymes to prevent prostaglandin-driven inflammation. Its rapid corneal penetration and long duration of action make it an effective choice for managing post-cataract surgery inflammation. For a full overview of the drug, see What Is Nevanac? Uses, Dosage, and What You Need to Know. If you need help finding it at a pharmacy near you, medfinder can help.